{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:06:44Z","timestamp":1791475604359,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-00178"],"award-info":[{"award-number":["2021-00178"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01030"],"award-info":[{"award-number":["2020-01030"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2024-00721"],"award-info":[{"award-number":["2024-00721"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021594","name":"Demensfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004472","name":"Riksbankens Jubileumsfond","doi-asserted-by":"publisher","award":["P22-0785 2023"],"award-info":[{"award-number":["P22-0785 2023"]}],"id":[{"id":"10.13039\/501100004472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018163","name":"Margareta af Ugglas Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018163","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Karolinska Institutet Strategic Research Area in Epidemiology and Biostatistics","id":[{"id":"https:\/\/ror.org\/056d84691","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Karolinska Institute","id":[{"id":"https:\/\/ror.org\/056d84691","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-02038-1","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T07:32:38Z","timestamp":1765956758000},"page":"7245-7260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Blood-based biomarkers of Alzheimer\u2019s disease and olfactory decline over 15 years in older adults"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-8410","authenticated-orcid":false,"given":"Ingrid","family":"Ekstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Liborio","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Valletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ruane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fredolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika J.","family":"Laukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"8","key":"2038_CR1","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/gerona\/glx054","volume":"72","author":"J Seubert","year":"2017","unstructured":"Seubert J, Laukka EJ, Rizzuto D, et al. Prevalence and correlates of olfactory dysfunction in old age: a population-based study. J Gerontol A Biol Sci Med Sci. 2017;72(8):1072\u20139. https:\/\/doi.org\/10.1093\/gerona\/glx054.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2038_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/1945892420946254","volume":"35","author":"VM Desiato","year":"2021","unstructured":"Desiato VM, Levy DA, Byun YJ, Nguyen SA, Soler ZM, Schlosser RJ. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. 2021;35(2):195\u2013205. https:\/\/doi.org\/10.1177\/1945892420946254.","journal-title":"Am J Rhinol Allergy"},{"key":"2038_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2014.00020","volume":"5","author":"RL Doty","year":"2014","unstructured":"Doty RL, Kamath V. The influences of age on olfaction: a review. Front Psychol. 2014;5:20. https:\/\/doi.org\/10.3389\/fpsyg.2014.00020.","journal-title":"Front Psychol"},{"issue":"3","key":"2038_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/20416695211020331","volume":"12","author":"JK Olofsson","year":"2021","unstructured":"Olofsson JK, Ekstr\u00f6m I, Larsson M, Nordin S. Olfaction and aging: a review of the current state of research and future directions. i-Perception. 2021;12(3):20416695211020331.","journal-title":"i-Perception"},{"issue":"1","key":"2038_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbr.2012.02.047","volume":"231","author":"S Rahayel","year":"2012","unstructured":"Rahayel S, Frasnelli J, Joubert S. The effect of Alzheimer\u2019s disease and Parkinson\u2019s disease on olfaction: a meta-analysis. Behav Brain Res. 2012;231(1):60\u201374. https:\/\/doi.org\/10.1016\/j.bbr.2012.02.047.","journal-title":"Behav Brain Res"},{"issue":"2","key":"2038_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1590\/1980-57642018dn13-020003","volume":"13","author":"MME Silva","year":"2019","unstructured":"Silva MME, Viveiros CP, Kotsifas NJE, et al. Olfactory impairment in frontotemporal dementia: a systematic review and meta-analysis. Dement Neuropsychol. 2019;13(2):154\u201361. https:\/\/doi.org\/10.1590\/1980-57642018dn13-020003.","journal-title":"Dement Neuropsychol"},{"issue":"1","key":"2038_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00441-017-2733-6","volume":"373","author":"MG Cersosimo","year":"2018","unstructured":"Cersosimo MG. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies. Cell Tissue Res. 2018;373(1):233\u201343. https:\/\/doi.org\/10.1007\/s00441-017-2733-6.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"2038_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/S1355617713001409","volume":"20","author":"I Stanciu","year":"2014","unstructured":"Stanciu I, Larsson M, Nordin S, Adolfsson R, Nilsson LG, Olofsson JK. Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: a longitudinal, population-based study. J Int Neuropsychol Soc. 2014;20(2):209\u201317. https:\/\/doi.org\/10.1017\/S1355617713001409.","journal-title":"J Int Neuropsychol Soc"},{"issue":"2","key":"2038_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1212\/WNL.0000000000001132","volume":"84","author":"DP Devanand","year":"2015","unstructured":"Devanand DP, Lee S, Manly J, et al. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community. Neurology. 2015;84(2):182\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000001132.","journal-title":"Neurology"},{"issue":"2","key":"2038_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jalz.2019.08.200","volume":"16","author":"DP Devanand","year":"2020","unstructured":"Devanand DP, Lee S, Luchsinger JA, et al. Intact global cognitive and olfactory ability predicts lack of transition to dementia. Alzheimers Dement. 2020;16(2):326\u201334. https:\/\/doi.org\/10.1016\/j.jalz.2019.08.200.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2038_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/jgs.15048","volume":"66","author":"DR Adams","year":"2018","unstructured":"Adams DR, Kern DW, Wroblewski KE, McClintock MK, Dale W, Pinto JM. Olfactory dysfunction predicts subsequent dementia in older U.S. adults. J Am Geriatr Soc. 2018;66(1):140\u20134. https:\/\/doi.org\/10.1111\/jgs.15048.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"2038_CR12","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1002\/alz.12932","volume":"19","author":"EJ Laukka","year":"2023","unstructured":"Laukka EJ, Ekstr\u00f6m I, Larsson M, Grande G, Fratiglioni L, Rizzuto D. Markers of olfactory dysfunction and progression to dementia: a 12-year population-based study. Alzheimers Dement. 2023;19(7):3019\u201327. https:\/\/doi.org\/10.1002\/alz.12932.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2038_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/lary.28166","volume":"130","author":"MJ Windon","year":"2020","unstructured":"Windon MJ, Kim SJ, Oh ES, Lin SY. Predictive value of olfactory impairment for cognitive decline among cognitively normal adults. Laryngoscope. 2020;130(4):840\u20137. https:\/\/doi.org\/10.1002\/lary.28166.","journal-title":"Laryngoscope"},{"key":"2038_CR14","doi-asserted-by":"publisher","unstructured":"Jack CR Jr, Andrews JS, Beach TG, et al. <article-title update=\"added\">Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup. Alzheimers Dement. 2024;20(8):5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859.","DOI":"10.1002\/alz.13859"},{"issue":"4","key":"2038_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3233\/JAD-2010-100696","volume":"22","author":"A Bahar-Fuchs","year":"2010","unstructured":"Bahar-Fuchs A, Ch\u00e9telat G, Villemagne VL, et al. Olfactory deficits and amyloid-\u03b2 burden in Alzheimer\u2019s disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis. 2010;22(4):1081\u20137. https:\/\/doi.org\/10.3233\/JAD-2010-100696.","journal-title":"J Alzheimers Dis"},{"key":"2038_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.586330","volume":"14","author":"L Tu","year":"2020","unstructured":"Tu L, Lv X, Fan Z, Zhang M, Wang H, Yu X. Association of odor identification ability with amyloid-\u03b2 and tau burden: a systematic review and meta-analysis. Front Neurosci. 2020;14:586330. https:\/\/doi.org\/10.3389\/fnins.2020.586330.","journal-title":"Front Neurosci"},{"issue":"3","key":"2038_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3233\/JAD-201149","volume":"80","author":"J Klein","year":"2021","unstructured":"Klein J, Yan X, Johnson A, et al. Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer\u2019s disease. J Alzheimers Dis. 2021;80(3):1051\u201365. https:\/\/doi.org\/10.3233\/JAD-201149.","journal-title":"J Alzheimers Dis"},{"key":"2038_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.dadm.2017.09.001","volume":"9","author":"SL Risacher","year":"2017","unstructured":"Risacher SL, Tallman EF, West JD, et al. Olfactory identification in subjective cognitive decline and mild cognitive impairment: association with tau but not amyloid positron emission tomography. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017;9:57\u201366. https:\/\/doi.org\/10.1016\/j.dadm.2017.09.001.","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"21","key":"2038_CR19","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1212\/WNL.0000000000001614","volume":"84","author":"ME Growdon","year":"2015","unstructured":"Growdon ME, Schultz AP, Dagley AS, et al. Odor identification and Alzheimer disease biomarkers in clinically normal elderly. Neurology. 2015;84(21):2153\u201360. https:\/\/doi.org\/10.1212\/WNL.0000000000001614.","journal-title":"Neurology"},{"issue":"3","key":"2038_CR20","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3233\/JAD-170564","volume":"60","author":"BLR Reijs","year":"2017","unstructured":"Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, et al. Relation of odor identification with Alzheimer\u2019s disease markers in cerebrospinal fluid and cognition. J Alzheimers Dis. 2017;60(3):1025\u201334. https:\/\/doi.org\/10.3233\/JAD-170564.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2038_CR21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3233\/JAD-210636","volume":"86","author":"Q Tian","year":"2022","unstructured":"Tian Q, Bilgel M, Moghekar AR, Ferrucci L, Resnick SM. Olfaction, cognitive impairment, and PET biomarkers in community-dwelling older adults. J Alzheimers Dis. 2022;86(3):1275\u201385. https:\/\/doi.org\/10.3233\/JAD-210636.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"2038_CR22","doi-asserted-by":"publisher","first-page":"e964","DOI":"10.1212\/WNL.0000000000201646","volume":"100","author":"Q Tian","year":"2023","unstructured":"Tian Q, An Y, Kitner-Triolo MH, et al. Associations of olfaction with longitudinal trajectories of brain volumes and neuropsychological function in older adults. Neurology. 2023;100(9):e964\u201374. https:\/\/doi.org\/10.1212\/WNL.0000000000201646.","journal-title":"Neurology"},{"issue":"3","key":"2038_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, et al. <article-title update=\"added\">Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2010Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2038_CR24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/gerona\/glv072","volume":"70","author":"JM Pinto","year":"2015","unstructured":"Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK. The rate of age-related olfactory decline among the general population of older U.S. adults. J Gerontol A Biol Sci Med Sci. 2015;70(11):1435\u201341. https:\/\/doi.org\/10.1093\/gerona\/glv072.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"2038_CR25","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/gerona\/glaa221","volume":"75","author":"I Ekstr\u00f6m","year":"2020","unstructured":"Ekstr\u00f6m I, Larsson M, Rizzuto D, Fastbom J, B\u00e4ckman L, Laukka EJ. Predictors of olfactory decline in aging: a longitudinal population-based study. J Gerontol A Biol Sci Med Sci. 2020;75(12):2441\u20139. https:\/\/doi.org\/10.1093\/gerona\/glaa221.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"18","key":"2038_CR26","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1001\/jama.288.18.2307","volume":"288","author":"C Murphy","year":"2002","unstructured":"Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002;288(18):2307\u201312. https:\/\/doi.org\/10.1001\/jama.288.18.2307.","journal-title":"JAMA"},{"key":"2038_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopha.2016.11.118","volume":"85","author":"GS Aseervatham","year":"2017","unstructured":"Aseervatham GS, Choi S, Krishnan J, Ruckmani K. Cigarette smoke and related risk factors in neurological disorders: an update. Biomed Pharmacother. 2017;85:79\u201386. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.118.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2038_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/ije\/dyy230","volume":"48","author":"V Gallo","year":"2019","unstructured":"Gallo V, Vineis P, Cancellieri M, et al. Exploring causality of the association between smoking and Parkinson\u2019s disease. Int J Epidemiol. 2019;48(3):912\u201325. https:\/\/doi.org\/10.1093\/ije\/dyy230.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"2038_CR29","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/lary.26558","volume":"127","author":"GS Ajmani","year":"2017","unstructured":"Ajmani GS, Suh HH, Wroblewski KE, Pinto JM. Smoking and olfactory dysfunction: a systematic literature review and meta-analysis. Laryngoscope. 2017;127(8):1753\u201361. https:\/\/doi.org\/10.1002\/lary.26558.","journal-title":"Laryngoscope"},{"issue":"11","key":"2038_CR30","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/acn3.51670","volume":"9","author":"AJ Aschenbrenner","year":"2022","unstructured":"Aschenbrenner AJ, Li Y, Henson RL, et al. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol. 2022;9(11):1739\u201351. https:\/\/doi.org\/10.1002\/acn3.51670.","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"2038_CR31","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, et al. The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 2022;18(12):2669\u201386. https:\/\/doi.org\/10.1002\/alz.12756.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2038_CR32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213706","volume":"104","author":"S Shrestha","year":"2025","unstructured":"Shrestha S, Zhu X, Griswold ME, et al. Olfaction and plasma biomarkers of Alzheimer disease and neurodegeneration in the Atherosclerosis Risk in Communities Study. Neurology. 2025;104(11):e213706. https:\/\/doi.org\/10.1212\/WNL.0000000000213706.","journal-title":"Neurology"},{"issue":"9","key":"2038_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","volume":"81","author":"S Janelidze","year":"2024","unstructured":"Janelidze S, Barth\u00e9lemy NR, Salvad\u00f3 G, et al. Plasma phosphorylated tau 217 and A\u03b242\/40 to predict early brain A\u03b2 accumulation in people without cognitive impairment. JAMA Neurol. 2024;81(9):947\u201357. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2619.","journal-title":"JAMA Neurol"},{"issue":"3","key":"2038_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 2024;81(3):255\u201363. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5319.","journal-title":"JAMA Neurol"},{"key":"2038_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neurobiolaging.2015.11.012","volume":"38","author":"M Larsson","year":"2016","unstructured":"Larsson M, Hedner M, Papenberg G, Seubert J, B\u00e4ckman L, Laukka EJ. Olfactory memory in the old and very old: relations to episodic and semantic memory and APOE genotype. Neurobiol Aging. 2016;38:118\u201326. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.012.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"2038_CR36","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/gerona\/glw233","volume":"72","author":"A Calder\u00f3n-Larra\u00f1aga","year":"2017","unstructured":"Calder\u00f3n-Larra\u00f1aga A, Vetrano DL, Onder G, et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J Gerontol A Biol Sci Med Sci. 2017;72(10):1417\u201323. https:\/\/doi.org\/10.1093\/gerona\/glw233.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2038_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/20416695211009928","volume":"12","author":"I Ekstr\u00f6m","year":"2021","unstructured":"Ekstr\u00f6m I, Vetrano DL, Papenberg G, Laukka EJ. Serum C-reactive protein is negatively associated with olfactory identification ability in older adults. i-Perception. 2021;12(2):20416695211009928. https:\/\/doi.org\/10.1177\/20416695211009928.","journal-title":"i-Perception"},{"issue":"6","key":"2038_CR38","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1002\/alz.13860","volume":"20","author":"M Valletta","year":"2024","unstructured":"Valletta M, Vetrano DL, Rizzuto D, et al. Blood biomarkers of Alzheimer\u2019s disease in the community: variation by chronic diseases and inflammatory status. Alzheimers Dement. 2024;20(6):4115\u201325. https:\/\/doi.org\/10.1002\/alz.13860.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2038_CR39","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande G, Valletta M, Rizzuto D, et al. Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat Med. 2025;31(6):2027\u201335. https:\/\/doi.org\/10.1038\/s41591-025-03605-x.","journal-title":"Nat Med"},{"issue":"1","key":"2038_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/chemse\/22.1.39","volume":"22","author":"T Hummel","year":"1997","unstructured":"Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. \u201cSniffin\u2019 sticks\u201d: olfactory performance assessed by the combined testing of odor identification, odor discrimination, and olfactory threshold. Chem Senses. 1997;22(1):39\u201352. https:\/\/doi.org\/10.1093\/chemse\/22.1.39.","journal-title":"Chem Senses"},{"issue":"8","key":"2038_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/chemse\/bjp057","volume":"34","author":"A Haehner","year":"2009","unstructured":"Haehner A, Mayer AM, Landis BN, et al. High test\u2013retest reliability of the extended version of the \u201cSniffin\u2019 Sticks\u201d test. Chem Senses. 2009;34(8):705\u201311. https:\/\/doi.org\/10.1093\/chemse\/bjp057.","journal-title":"Chem Senses"},{"issue":"1","key":"2038_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43\u20136.","journal-title":"Epidemiology"},{"issue":"17","key":"2038_CR43","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","volume":"87","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Zetterberg H, Janelidze S, et al. Plasma tau in Alzheimer disease. Neurology. 2016;87(17):1827\u201335. https:\/\/doi.org\/10.1212\/WNL.0000000000003246.","journal-title":"Neurology"},{"issue":"8","key":"2038_CR44","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","volume":"17","author":"AM Brickman","year":"2021","unstructured":"Brickman AM, Manly JJ, Honig LS, et al. <article-title update=\"added\">Plasma p\u2010tau181, p\u2010tau217, and other blood\u2010based Alzheimer\u2019s disease biomarkers in a multi\u2010ethnic, community study. Alzheimers Dement. 2021;17(8):1353\u201364. https:\/\/doi.org\/10.1002\/alz.12301.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"2038_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19(5):422\u201333. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5.","journal-title":"Lancet Neurol"},{"issue":"7","key":"2038_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41582-022-00665-2","volume":"18","author":"TK Karikari","year":"2022","unstructured":"Karikari TK, Ashton NJ, Brinkmalm G, et al. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility. Nat Rev Neurol. 2022;18(7):400\u201318. https:\/\/doi.org\/10.1038\/s41582-022-00665-2.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2038_CR47","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/biomedicines10051077","volume":"10","author":"P LoPresti","year":"2022","unstructured":"LoPresti P. Serum-based biomarkers in neurodegeneration and multiple sclerosis. Biomedicines. 2022;10(5):1077. https:\/\/doi.org\/10.3390\/biomedicines10051077.","journal-title":"Biomedicines"},{"issue":"5","key":"2038_CR48","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000271","volume":"3","author":"J Bergman","year":"2016","unstructured":"Bergman J, Dring A, Zetterberg H, et al. Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS. Neurol Neuroimmunol Neuroinflamm. 2016;3(5):e271. https:\/\/doi.org\/10.1212\/NXI.0000000000000271.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"2038_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14621","volume":"21","author":"NJ Ashton","year":"2025","unstructured":"Ashton NJ, Benedet AL, Molfetta GD, et al. Biomarker discovery in Alzheimer\u2019s and neurodegenerative diseases using nucleic acid linked immuno-sandwich assay. Alzheimers & Dementia. 2025;21(5):e14621. https:\/\/doi.org\/10.1002\/alz.14621.","journal-title":"Alzheimers & Dementia"},{"issue":"Suppl 1","key":"2038_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1017\/S1041610297004973","volume":"9","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Staging of Alzheimer-related cortical destruction. Int Psychogeriatr. 1997;9(Suppl 1):257\u201372.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"2038_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01508-7","volume":"7","author":"M Josefsson","year":"2017","unstructured":"Josefsson M, Larsson M, Nordin S, Adolfsson R, Olofsson J. APOE-\u03b54 effects on longitudinal decline in olfactory and non-olfactory cognitive abilities in middle-aged and old adults. Sci Rep. 2017;7(1):1286. https:\/\/doi.org\/10.1038\/s41598-017-01508-7.","journal-title":"Sci Rep"},{"key":"2038_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropsychologia.2016.03.004","volume":"85","author":"JK Olofsson","year":"2016","unstructured":"Olofsson JK, Josefsson M, Ekstr\u00f6m I, et al. Long-term episodic memory decline is associated with olfactory deficits only in carriers of ApoE-\u04544. Neuropsychologia. 2016;85:1\u20139. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2016.03.004.","journal-title":"Neuropsychologia"},{"issue":"7","key":"2038_CR53","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1212\/WNL.53.7.1480","volume":"53","author":"AB Graves","year":"1999","unstructured":"Graves AB, Bowen JD, Rajaram L, et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E \u03b54 status. Neurology. 1999;53(7):1480\u20137. https:\/\/doi.org\/10.1212\/WNL.53.7.1480.","journal-title":"Neurology"},{"issue":"5","key":"2038_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3524","volume":"14","author":"C Frank","year":"2024","unstructured":"Frank C, Albertazzi A, Murphy C. The effect of the apolipoprotein E \u03b54 allele and olfactory function on odor identification networks. Brain Behav. 2024;14(5):e3524. https:\/\/doi.org\/10.1002\/brb3.3524.","journal-title":"Brain Behav"},{"issue":"6","key":"2038_CR55","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000116984","volume":"33","author":"H Braak","year":"1993","unstructured":"Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol. 1993;33(6):403\u20138. https:\/\/doi.org\/10.1159\/000116984.","journal-title":"Eur Neurol"},{"issue":"4","key":"2038_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2038_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/brain\/awaa399","volume":"144","author":"A Moscoso","year":"2021","unstructured":"Moscoso A, Grothe MJ, Ashton NJ, et al. Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum. Brain. 2021;144(1):325\u201339. https:\/\/doi.org\/10.1093\/brain\/awaa399.","journal-title":"Brain"},{"issue":"4","key":"2038_CR58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","volume":"80","author":"N Mattsson-Carlgren","year":"2023","unstructured":"Mattsson-Carlgren N, Salvad\u00f3 G, Ashton NJ, et al. Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers. JAMA Neurol. 2023;80(4):360\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2022.5272.","journal-title":"JAMA Neurol"},{"issue":"8","key":"2038_CR59","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324(8):772\u201381. https:\/\/doi.org\/10.1001\/jama.2020.12134.","journal-title":"JAMA"},{"issue":"3","key":"2038_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","volume":"140","author":"J Lantero Rodriguez","year":"2020","unstructured":"Lantero Rodriguez J, Karikari TK, Su\u00e1rez-Calvet M, et al. Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathol. 2020;140(3):267\u201378. https:\/\/doi.org\/10.1007\/s00401-020-02195-x.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2038_CR61","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault J, Benedet AL, Pascoal TA, et al. Association of apolipoprotein E \u03b54 with medial temporal tau independent of amyloid-\u03b2. JAMA Neurol. 2020;77(4):470\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4421.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2038_CR62","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12889-024-17811-8","volume":"24","author":"N Zhu","year":"2024","unstructured":"Zhu N, Zhu J, Lin S, Yu H, Cao C. Correlation analysis between smoke exposure and serum neurofilament light chain in adults: a cross-sectional study. BMC Public Health. 2024;24(1):353. https:\/\/doi.org\/10.1186\/s12889-024-17811-8.","journal-title":"BMC Public Health"},{"key":"2038_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328547","author":"P Oeckl","year":"2022","unstructured":"Oeckl P, Anderl-Straub S, von Arnim CAF, et al. Serum GFAP differentiates Alzheimer\u2019s disease from frontotemporal dementia and predicts MCI-to-dementia conversion. J Neurol Neurosurg Psychiatry. 2022. https:\/\/doi.org\/10.1136\/jnnp-2021-328547.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2038_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00804-9","volume":"13","author":"C Cicognola","year":"2021","unstructured":"Cicognola C, Janelidze S, Hertze J, et al. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. Alzheimers Res Ther. 2021;13(1):68. https:\/\/doi.org\/10.1186\/s13195-021-00804-9.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2038_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","volume":"11","author":"P Chatterjee","year":"2021","unstructured":"Chatterjee P, Pedrini S, Stoops E, et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease. Transl Psychiatry. 2021;11(1):27. https:\/\/doi.org\/10.1038\/s41398-020-01137-1.","journal-title":"Transl Psychiatry"},{"key":"2038_CR66","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8860125","volume":"2023","author":"FJ Li","year":"2023","unstructured":"Li FJ, Li YDY, Liu X, et al. Serum biomarkers of olfactory identification deficits in patients with Parkinson\u2019s disease. Acta Neurol Scand. 2023;2023:8860125. https:\/\/doi.org\/10.1155\/2023\/8860125.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2038_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00846-9","volume":"20","author":"W Youn","year":"2025","unstructured":"Youn W, Yun M, Lee CJ, Sch\u00f6ll M. Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases. Mol Neurodegener. 2025;20(1):54. https:\/\/doi.org\/10.1186\/s13024-025-00846-9.","journal-title":"Mol Neurodegener"},{"key":"2038_CR68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fpsyg.2019.00242","volume":"10","author":"P Sorokowski","year":"2019","unstructured":"Sorokowski P, Karwowski M, Misiak M, et al. Sex differences in human olfaction: a meta-analysis. Front Psychol. 2019;10:242. https:\/\/doi.org\/10.3389\/fpsyg.2019.00242.","journal-title":"Front Psychol"},{"issue":"11","key":"2038_CR69","first-page":"14","volume":"35","author":"MM Mielke","year":"2018","unstructured":"Mielke MM. Sex and gender differences in Alzheimer\u2019s disease dementia. Psychiatr Times. 2018;35(11):14\u20137.","journal-title":"Psychiatr Times"},{"issue":"10\u201312","key":"2038_CR70","first-page":"19","volume":"19","author":"S Hasan","year":"2022","unstructured":"Hasan S, Adler CH, Zhang N, et al. Olfactory dysfunction in incidental Lewy body disease and Parkinson\u2019s disease: an update. Innov Clin Neurosci. 2022;19(10\u201312):19\u201323.","journal-title":"Innov Clin Neurosci"},{"issue":"3","key":"2038_CR71","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s11357-022-00556-w","volume":"44","author":"C Custodero","year":"2022","unstructured":"Custodero C, Ciavarella A, Panza F, et al. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis. Geroscience. 2022;44(3):1373\u201392. https:\/\/doi.org\/10.1007\/s11357-022-00556-w.","journal-title":"Geroscience"},{"issue":"10248","key":"2038_CR72","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","journal-title":"Lancet"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-02038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-02038-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-02038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:02:35Z","timestamp":1790186555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-02038-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":72,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2038"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-02038-1","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All parts of SNAC-K were approved by the ethical committee at Karolinska Institutet or the Regional Ethical Review Board in Stockholm (ethical permit for baseline: KI 01\u2013114). In compliance with the Declaration of Helsinki, all participants or their appropriate surrogates provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors occasionally used ChatGPT (OpenAI) to shorten the length of specific sentences. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","label":"Use of AI tools","group":{"name":"EthicsHeading","label":"Declarations"}}]}}